Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $9,432 - $11,576
99 New
99 $10,000
Q1 2021

May 12, 2021

SELL
$67.06 - $75.82 $61,359 - $69,375
-915 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $58,459 - $67,527
915 New
915 $64,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Standard Family Office LLC Portfolio

Follow Standard Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Standard Family Office LLC with notifications on news.